| Description | CP-316819 (GPi 819) is a potent inhibitor of glycogen phosphorylase (GPase) with hypoglycemic effects, inhibits huSMGPa and huLGPa, maintains neuronal activity during hypoglycemia, and can be used in the study of hyperglycemia. |
| Synonyms | CP 316819, GPi 819 |
| molecular weight | 415.87 |
| Molecular formula | C21H22ClN3O4 |
| CAS | 186392-43-8 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | Ethanol: <41.59 mg/mL DMSO: 100 mg/mL (240.46 mM), Sonication is recommended. |
| References | 1. Baker DJ, et al. Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle. Diabetes. 2005 Aug;54(8):2453-9. |